Genmab — Februar 2026
-
the first hospital in the UK treated a patient (outside of clinical trials) with Tepezza, but not currently available on the NHS https://harleystreetbid.com/newsevent/pharmacist-becomes-uks-first-patient-for-thyroid-eye-disease-treatment-tepezza-at-the-london-clinic/
-
Genmab skal få fart på Peto i sc version https://www.prnewswire.com/news-releases/merus-and-halozyme-enter-global-collaboration-and-license-agreement-to-develop-subcutaneous-formulation-of-petosemtamab-302616859.html Den fordel skal
Amivantamab ikke have. -
Novo Nordisk vil have Genmabs topchef i bestyrelsen https://proinvestor.com/investornyt/1413719/novo-nordisk-vil-have-genmabs-topchef-i-bestyrelsen
-
Oversigt: Ny udgave af ØU Life Science – Genmab straffes for guidance, pipeline-optionalitet forbliver uprissat . https://proinvestor.com/investornyt/1413717/oversigt-ny-udgave-af-ou-life-science-genmab-straffes-for-guidance-pipeline-optionalitet-forbliver-uprissat (artikel kræver ikke abonnement) .
-
@Solsen: Hvis det bliver en realitet, hvor meget tid vil Winkel så have tilovers for Genmab?? - Rent tidsmæssigt kan du jo ikke bestride begge poster optimalt.
-
Novo er ikke et lille firma, så alene at sætte sig ind i alt bestyrelsesdokumentation tager sin tid vil jeg mene.
-
Helt bestemt. Så investeret som Winkel er i Genmab både arbejdsmæssigt (såvel som økonomisk), så giver det heller ikke mening i min optik. Hvis blot dette skulderklap også kunne smitte lidt af på kursen
-
@Solsen kl.11.10 - Uha, dette har jeg ikke været opmærksom på.... Dvs. at selvom Peto stadig viser sig amivantamab overlegent senere i år. Så vil amivantamab vel stadig være førstevalget for hospitalerne grundet SC udgaven?..... I så fald vil Peto jo så være et par år bagud?
-
Ja, så får Jan ihvertfald lidt flere penge.... at købe Genmab-aktier for
-
lol, it will be rather irrelevant compared to the package he receives at Genmab... I am a bit surprised that he thinks he has enough time to take on that role, but good for him. it is a good thing for his reputation, and i would think therefore good for genmab
-
Winkel can as a board member of NOVO even work for on a strategic level that NOVO buys Genmab
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind